DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
TAMPA, FL / ACCESS Newswire / November 9, 2026 / DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") MEDS , a healthcare company that integrates its health information…
DO
By Daniel Okafor · Regulatory Correspondent
Nov 9 06:00 ETSource: TradingView
From the source
Read at tradingview.comDataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
TAMPA, FL / ACCESS Newswire / November 9, 2026 / DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") MEDS , a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx™ artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that its Corexa Pharmacy subsidiary has complete
